Editorial Commentary
Sentinel node mapping in endometrial cancer
Translational Cancer Research
2019;
8
(6)
:2218-2219
.
(30 October 2019)
Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
Translational Cancer Research
2019;
8
(6)
:2220-2222
.
(30 October 2019)
Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?
Translational Cancer Research
2019;
8
(6)
:2223-2229
.
(30 October 2019)
Original Article
NKG2D-IL-15 fusion protein encapsulated in N-[(2-hydroxy-3-trimethylammonium) propyl] chitosan chloride retards melanoma growth in mice
Translational Cancer Research
2019;
8
(6)
:2230-2241
.
(30 October 2019)
Eukaryotic translation initiation factor 3B downregulation inhibits cell proliferation and promotes cell apoptosis through negatively regulating tumor necrosis factor receptor superfamily member 21 in gastric cancer
Translational Cancer Research
2019;
8
(6)
:2242-2251
.
(30 October 2019)
KIF18A promotes head and neck squamous cell carcinoma invasion and migration via activation of Akt signaling pathway
Translational Cancer Research
2019;
8
(6)
:2252-2263
.
(30 October 2019)
Identification of plasma exosomes long non-coding RNA HAGLR and circulating tumor cells as potential prognosis biomarkers in non-small cell lung cancer
Translational Cancer Research
2019;
8
(6)
:2264-2273
.
(30 October 2019)
Effect of NOP2 knockdown on colon cancer cell proliferation, migration, and invasion
Translational Cancer Research
2019;
8
(6)
:2274-2283
.
(30 October 2019)
Octreotide treatment of cancer chemoradiotherapy-induced diarrhoea: a meta-analysis of randomized controlled trials
Translational Cancer Research
2019;
8
(6)
:2284-2294
.
(30 October 2019)
Overexpression of Raf-1 kinase inhibitor protein inhibits cell invasion and migration in lung cancer cells through suppressing epithelial-mesenchymal transition
Translational Cancer Research
2019;
8
(6)
:2295-2306
.
(30 October 2019)
Knockdown of METTL14 inhibits the growth and invasion of cervical cancer
Translational Cancer Research
2019;
8
(6)
:2307-2315
.
(30 October 2019)
Identification of molecular markers for pre-thrombotic state: validation in the rabbits with tibia fracture or lung cancer
Translational Cancer Research
2019;
8
(6)
:2316-2327
.
(30 October 2019)
The regulatory role of aberrant methylation of microRNA-34a promoter CpGs in osteosarcoma
Translational Cancer Research
2019;
8
(6)
:2328-2338
.
(30 October 2019)
Screening of differential expressed genes from gene chip and sequencing data and evaluate its prognostic values in males with digestive system neoplasms
Translational Cancer Research
2019;
8
(6)
:2339-2349
.
(30 October 2019)
Clinicopathological characteristics with EGFR, ALK, ROS1 genetic alternation and prognostic analysis of primary lymphoepithelioma-like carcinoma
Translational Cancer Research
2019;
8
(6)
:2350-2356
.
(30 October 2019)
An observational study of vascular endothelial growth factor inhibitors as second-line treatment for metastatic colorectal cancer treated with bevacizumab plus FOLFIRI beyond progression: the association with RAS mutation and tumor sidedness
Translational Cancer Research
2019;
8
(6)
:2357-2370
.
(30 October 2019)
Application of metabolomics by UHPLC-MS/MS in diagnostics and biomarker discovery of non-small cell lung cancer
Translational Cancer Research
2019;
8
(6)
:2371-2379
.
(30 October 2019)
Helicase lymphoid-specifics and selenoprotein P1 are potential candidate genes in the progression and prognosis of lung adenocarcinoma
Translational Cancer Research
2019;
8
(6)
:2380-2388
.
(30 October 2019)
Expression of neuritin in human lung squamous cell carcinoma
Translational Cancer Research
2019;
8
(6)
:2389-2395
.
(30 October 2019)
Clinicopathologic factors associated with short-term survival in advanced epithelial ovarian cancer
Translational Cancer Research
2019;
8
(6)
:2396-2404
.
(30 October 2019)
Infiltrating regulatory T cells promote invasiveness of liver cancer cells via inducing epithelial-mesenchymal transition
Translational Cancer Research
2019;
8
(6)
:2405-2415
.
(30 October 2019)
TRIANGLE operation for borderline resectable pancreatic cancer in total pancreatectomy
Translational Cancer Research
2019;
8
(6)
:2416-2424
.
(30 October 2019)
Blockade of AXL activation overcomes acquired resistance to EGFR tyrosine kinase inhibition in non-small cell lung cancer
Translational Cancer Research
2019;
8
(6)
:2425-2438
.
(30 October 2019)
TNF-α promotes tumor lymph angiogenesis in head and neck squamous cell carcinoma through regulation of ERK3
Translational Cancer Research
2019;
8
(6)
:2439-2448
.
(30 October 2019)
Withaferin A suppresses skin tumor promotion by inhibiting proteasome-dependent isocitrate dehydrogenase 1 degradation
Translational Cancer Research
2019;
8
(6)
:2449-2460
.
(30 October 2019)
Cinobufagin inhibits tumor growth by inducing apoptosis through Notch signaling pathways in human cholangiocarcinoma
Translational Cancer Research
2019;
8
(6)
:2461-2469
.
(30 October 2019)
MicroRNA-497-5p negatively regulates the proliferation and cisplatin resistance of non-small cell lung cancer cells by targeting YAP1 and TEAD1
Translational Cancer Research
2019;
8
(6)
:2470-2480
.
(30 October 2019)
Brief Report
Rivaroxaban treatment for cancer-associated venous thromboembolism in a patient with heparin-induced thrombocytopenia: a case report
Translational Cancer Research
2019;
8
(6)
:2481-2484
.
(30 October 2019)
Review Article
Prognostic relevance of genetic variations in T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma
Translational Cancer Research
2019;
8
(6)
:2485-2495
.
(30 October 2019)
Case Report
A case of pulmonary benign metastasizing leiomyoma: clinicopathologic, immunohistochemical, and PET/CT analyses
Translational Cancer Research
2019;
8
(6)
:2496-2503
.
(30 October 2019)
Letter to the Editor
Analysis of The Cancer Genome Atlas data to determine the correlation between AGO2, TERT, and TERC in various cancers
Translational Cancer Research
2019;
8
(6)
:2504-2505
.
(30 October 2019)
Response to the hunt for the perfect biomarker in nasopharyngeal carcinoma—the RRAS “race” beyond Epstein-barr virus?
Translational Cancer Research
2019;
8
(6)
:2506-2507
.
(30 October 2019)
